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Abstract
Background: Infectious diarrhea leads to significant mortality in children, with 40 % of these deaths occurring in
Africa. Classic human astroviruses are a well-established etiology of diarrhea. In recent years, seven novel astroviruses
have been discovered (MLB1, MLB2, MLB3, VA1/HMO-C, VA2/HMO-B, VA3/HMO-A, VA4); however, there have been
few studies on their prevalence or potential association with diarrhea.
Methods: To investigate the prevalence and diversity of these classic and recently described astroviruses in a
pediatric population, a case–control study was performed. Nine hundred and forty nine stools were previously
collected from cases of moderate-to-severe diarrhea and matched controls of patients less than 5 years of age in
Kenya and The Gambia. RT-PCR screening was performed using pan-astrovirus primers.
Results: Astroviruses were present in 9.9 % of all stool samples. MLB3 was the most common astrovirus with a
prevalence of 2.6 %. Two subtypes of MLB3 were detected that varied based on location in Africa. In this
case–control study, Astrovirus MLB1 was associated with diarrhea in Kenya, whereas Astrovirus MLB3 was associated
with the control state in The Gambia. Classic human astrovirus was not associated with diarrhea in this study.
Unexpectedly, astroviruses with high similarity to Canine Astrovirus and Avian Nephritis Virus 1 and 2 were also
found in one case of diarrhea and two control stools respectively.
Conclusions: Astroviruses including novel MLB- and VA-clade members are commonly found in pediatric stools in
Kenya and The Gambia. The most recently discovered astrovirus, MLB3, was the most prevalent and was found
more commonly in control stools in The Gambia, while astrovirus MLB1 was associated with diarrhea in Kenya.
Furthermore, a distinct subtype of MLB3 was noted, as well as 3 unanticipated avian or canine astroviruses in the
human stool samples. As a result of a broadly reactive PCR screen for astroviruses, new insight was gained regarding
the epidemiology of astroviruses in Africa, where a large proportion of diarrheal morbidity and mortality occur.
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Background
Diarrheal disease is a leading cause of death in children
under five years of age worldwide [1], and a high propor-
tion of these deaths, approximately 40 %, occur in Africa
[2]; however this population has been rarely studied [3].
Additionally, infectious diarrhea causes significant mor-
bidity including growth faltering, malnutrition and im-
paired cognitive development [4].
Classic human astroviruses (HAstV) are a well-established
etiology of viral gastroenteritis, causing approximately 2 %
to 8 % of childhood diarrhea in Africa [5–10]. All 8 sero-
types of HAstV have been associated with diarrhea. Since
2008, seven highly divergent astroviruses (MLB1, MLB2,
MLB3, VA1/HMO-C, VA2/HMO-B, VA3/HMO-A, VA4)
have been discovered in human stool samples [11–16]. To
date, there have been few prevalence studies and no de-
finitive disease association established for these viruses.
MLB1 was the first of these to be discovered and has
been detected in stools across the world including
Australia, Asia, Africa, North America and Europe [11,
13, 15–22]. Furthermore a seroepidemiologic study of
MLB1 demonstrated that primary exposure occurs in
childhood and that seropositivity reached 100 % by
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adulthood [23]. One case–control study of MLB1 has
been reported of Indian children that did not show an
association of MLB1 with diarrhea [24]. MLB2 was ini-
tially discovered in stool, and MLB2 viremia in a febrile
child has been described [25]. MLB3 was described re-
cently in India in 2013 and found in 0.6 % of stools sam-
pled [12].
VA1/HMO-C was first identified in an unexplained
outbreak of gastroenteritis [14] and has since been de-
tected in the brain of multiple immunocompromised pa-
tients with encephalitis [26–28]. This virus has been
found to have a seroprevalence of 65 % in adults [29].
VA2/HMO-A and VA3/HMO-B have been described in
stools from Nigeria, Pakistan, and India, while VA2/
HMO-A has additionally been found in stools from the
United States, China and Egypt [11, 13, 18, 21]. VA4 was
recently discovered in 2 stool samples from Nepal [12].
Due to the limited data on these novel astroviruses,
the objective of this study was to explore the prevalence
and diversity of astroviruses in a pediatric population
using cases of moderate-severe diarrhea (MSD) and
matched controls in Kenya and The Gambia.
Results
Astroviruses were present in 9.9 % of all samples and
represented primarily a mixture of classic, MLB and VA
astroviruses (MLB3 2.6 %, HAstV 2.5 %, MLB1 1.7 %)
(Table 1). MLB3 was the most prevalent astrovirus,
followed by HAstV and MLB1.
MLB3 was detected more frequently in controls than
in diarrhea cases in The Gambia (4.7 % controls vs 1.1 %
cases; p = 0.0421) as well as overall (4.2 % controls vs
0.9 % cases; p = 0.0071). Sequencing of the amplicons
from the MLB3 positive samples from 6 of 7 Kenyan
samples yielded sequences that shared 97-99 % identity
with the reference MLB3 strain. However, the seventh
Kenyan sample and all 18 positive samples from The
Gambia shared only 88–89 % identity to the reference
MLB3 strain, demonstrating that a previously unrecognized
diversity of MLB3 subtypes exists (Fig. 1).
MLB1 was significantly associated with diarrhea in
Kenya (6.1 % cases vs 0.6 % controls; p = 0.0217). All of
the MLB1 positive stools in Kenya occurred in a 4 month
timeframe of stool collection between May-August of
2008 with 7 of the 12 positive samples collected within
12 days. By contrast, prevalence of MLB1 was lower in
The Gambia, 3 of the 4 detections occurred in March
and April, and no association with diarrhea was ob-
served (0.8 % cases vs. 0.6 % controls). There was no dif-
ference in the prevalence of classic astroviruses between
cases and controls (2.7 % cases vs. 2.4 % controls). VA-
clade viruses were detected at low prevalence (VA1 and
VA2) or not at all (VA3 and VA4).
The results of previous microbiologic testing for 17
diarrhea pathogens for these samples [3] were used to
determine if any of the known pathogens were detected
with any astrovirus more frequently than by chance.
Prevalence of Campylobacter jejuni infections in the ag-
gregate Kenya and The Gambia population was 4.5 %
(5.8 % of cases and 3.4 % of controls) (Table 2). Co-
detection of MLB1 and Campylobacter jejuni was signifi-
cant; 5 of the 16 stools positive for MLB1 were also positive
for C. jejuni (p = 0.0005). All five of the samples with both
MLB1 and C. jejuni were diarrhea cases.
Sequencing of the pan-astrovirus primer derived ampli-
cons also yielded several unexpected results. A 415 nucleo-
tide (nt) amplicon [GenBank: KJ777800] from a Kenyan
case stool shared 95 % nucleotide identity to Canine as-
trovirus strain 915 [GenBank: JX878480]. In addition, a
439 nt amplicon [GenBank: KJ777802] from a Kenyan
Table 1 Astrovirus Screening Results
Kenya The Gambia All samples
Cases Controls p Cases Controls p Cases Controls p Total
n = 181 n = 181 n = 266 n = 321 n = 447 n = 502 n = 949
HAstV 7 4 0.3270 5 8 0.4609 12 12 0.9432 24
MLB1 11 1 0.0217* 2 2 1.000 13 3 0.0221* 16
MLB2 0 1 0.9907 2 7 0.2722 2 8 0.1808 10
MLB3 1 6 0.9864 3 15 0.0421* 4 21 0.0071* 25
VA1 0 0 N/A 0 1 0.9857 0 1 0.9857 1
VA2 2 2 1.0000 4 6 0.9435 6 8 0.9569 14
VA3 0 0 N/A 0 0 N/A 0 0 N/A 0
VA4 0 0 N/A 0 0 N/A 0 0 N/A 0
Total† 21 14 N/A 16 39 N/A 37 53 N/A 90
HAstV- Human Astrovirus
N/A- Not applicable
*Significant at p < 0.05
†Total does not include additional astroviruses including Canine Astrovirus, Avian Nephritis Virus 1 and 2, and VA5
Meyer et al. Virology Journal  (2015) 12:78 Page 2 of 7
control stool shared 92 % identity to Avian Nephritis Virus
2 [GenBank: HQ188698] [30], while a 439 nt amplicon
[GenBank: KJ777801] from a Gambian control sample
shared 94 % identity to Avian Nephritis Virus 1 [GenBank:
AB033998] [31]. Finally, a 433 nt amplicon from a control
sample from the Gambia shared only 77 % nucleotide
identity to VA4. We sequenced the nearly-complete gen-
ome of 6519 nt [GenBank: KJ656124], which we tenta-
tively named astrovirus VA5 (Fig. 2). Further analysis
demonstrated that this sequence shared 94 % nucleotide
identity to a very recently published sequence Human
astrovirus BF34 [GenBank: KF859964] [32]. VA5 contains
characteristic astrovirus motifs such as a heptameric slip-
pery sequence (AAAAAAC) and a stem-loop II in the 3′
UTR.
Discussion
In summary, astroviruses are commonly found in pe-
diatric stool samples in Kenya and The Gambia. While
there have been a few reports describing the prevalence
of recently identified astroviruses in African countries
such as Egypt and Nigeria [13, 18] there have been no
studies from Kenya or The Gambia. Astrovirus MLB3
was recently discovered in India in 2013 [12] and has
not been previously detected in Africa; however, it was
the most frequently detected of all of the astroviruses in
this study.
This is only the second study reporting MLB3 and the
first case–control study of MLB3 performed. Compared
to the initial study in India, MLB3 was detected at a
prevalence four times higher in Africa [12]. Furthermore,
there is a novel diversity of MLB3 viruses, as a distinct
subtype of MLB3 that differed by > 10 % from the refer-
ence MLB3 was detected. Prior studies of the 8 classic
human astrovirus serotypes have also shown geographic
strain variation [33].
Interestingly, MLB3 was negatively associated with
moderate-severe diarrhea in The Gambia. Although vi-
ruses are generally associated with undesirable conse-
quences, a recent animal model showed that enteric
viruses may also have beneficial functions [34]. In the ani-
mal model, murine norovirus provided protection against
mucosal damage and supported intestinal homeostasis in
germ-free and antibiotic-treated mice. The association of
MLB3 with the control state, may indicate that MLB3 can
similarly provide protection from diarrhea in this popula-
tion. Alternatively, MLB3 may be a pathogen of another
organ system and affected by diarrhea-associated changes
in the gut.
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Fig. 1 Phylogenetic Analysis of MLB3 amplicons. Amplicons measuring 409 nucleotides in length from ORF 1b were used for phylogenetic
analysis. Significant bootstrap values (>700) are shown. Scale bar represents the number of nucleic acid differences. GenBank accession numbers
or sample numbers are listed for reference
Table 2 Campylobacter jejuni and MLB1 Co-detection
MLB1 Negative MLB1 Positive Total
Campylobacter Negative 895 (94.3 %) 11 (1.2 %) 906
Campylobacter Positive 38 (4.0 %) 5 (0.5 %)* 43
Total 933 16 949
*Co-detection of MLB1 and Campylobacter jejuni was significant at p = 0.0005
using Fisher exact test, 95 % CI (2.757–35.260)
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There was a positive association between MLB1 and
diarrhea in this matched case–control study in Kenya,
raising the possibility that MLB1 may play a role in the
etiology of diarrhea. However, no association was ob-
served in The Gambia. In Kenya, there was a clustering
of positive stools over a 12 day time period. This could
indicate an outbreak of MLB1 leading to diarrhea and
increased prevalence that was not captured in The
Gambia. The association of MLB1 with diarrhea also dif-
fered from a prior case–control study in India [24]. Al-
though the aggregate analysis of Kenya and The Gambia
together still yields a statistically significant association
with diarrhea overall (p = 0.0221), the different results
from the two sites renders it difficult to make definitive
conclusions.
Clearly the two geographic sites yielded distinct pre-
valence rates for both MLB1 and MLB3. Geographic
variation of eukaryotic viruses occurs [35] and likely con-
tributed to our findings. These observations underscore
the need for additional studies in diverse geographic
sites to better define the prevalence of these novel
astroviruses.
This study showed a significant association between
MLB1 and C. jejuni. Campylobacter is typically a food-
borne or zoonotic disease [36], while classic human
astrovirus is most commonly transmitted by human to
human contact [33]. Although the route of transmission
of MLB1 is currently unknown, the high rate of co-
detection could be due to similar transmission of MLB1
and Campylobacter through food or water. Previous
studies have shown that mixed infections with Campylo-
bacter and other pathogens are common [37, 38], and
specific virus-induced cell alterations enhanced the inva-
siveness of C. jejuni in a cell culture model [39]. These
observations raise the question of whether there may be
synergistic effects between these agents and whether
those effects play a role in the etiology of diarrhea, as all
co-detections occurred in cases with diarrhea.
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Fig. 2 Phylogenetic Analysis of Astrovirus ORF2 capsid protein. The complete amino acid sequence from ORF2 was used for phylogenetic
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Although HAstV is a well-established cause of diar-
rhea, it was not associated with moderate-severe diar-
rhea in this study. This observation may be due to the
exclusion of mild cases of diarrhea typically associated
with HAstV infection. This result also reflects some of
the challenges of using the case–control approach for
disease attribution as other well-defined human diar-
rhea pathogens have also failed in single case–control
studies [40, 41].
Unexpectedly, there were sequences in human stool
with high identity to Avian Nephritis Virus 1 and 2 and
Canine Astrovirus. These observations may be the result
of ingestion of infected meat, as this phenomenon has
been described for plant viruses [17, 42] or may be re-
lated to environmental exposure to animals. Zoonotic
infection has been postulated to occur in astroviruses
due to the frequent occurrence of recombination events
and wide range of species infected [43] and is another
possibility. In addition, a novel astrovirus VA5, similar to
the recently reported HAstV-BF34 was identified [32]. It
was only the use of broadly reactive PCR primers in this
study that enabled the detection of these unexpected or
novel agents. Prior studies of the prevalence of classic
HAstV used primers that targeted specifically Human
Astroviruses 1–8. Those primers could not detect viruses
such as Avian Nephritis Virus or Canine Astrovirus. With
the dramatic increase the number of astrovirus species
discovered, further optimization of consensus astrovirus
primers and their application to analyze human cohorts
may uncover much more about the types and frequency of
astroviruses found in human stool.
Conclusions
In conclusion, astroviruses including the novel MLB- and
VA-clades are commonly found in pediatric stools in
Kenya and The Gambia and a wide range of astroviruses
was detected in this population. One of the most recently
discovered astroviruses, MLB3 was also the most prevalent.
MLB1 was associated with diarrhea in Kenya, while MLB3
was found more commonly in the control stools in The
Gambia. There is diversity within the species of MLB3. Un-
expected animal astrovirus species were detected in human
stool through the use of broadly reactive PCR primers.
Additional studies are needed to better understand the role
of these novel astroviruses in human health and disease.
Methods
Samples
This investigation utilized 949 stool samples from cases
of moderate-severe diarrhea and matched controls aged
0–59 months participating in the Global Enteric Multi-
center Study (GEMS) at two rural sites in Kenya and
The Gambia [3]. Samples were collected from Kenya be-
tween April 2008 and December 2008 and from The
Gambia between March 2008 and April 2009. The study
was approved by ethics committees at the University of
Maryland, Baltimore, MD, USA, and at both field sites.
Cases of moderate-severe diarrhea were defined as acute
(onset within 7 days) with ≥ 3 loose stools within 24 hours
and 1 of the following criteria: sunken eyes, loss of skin
turgor, intravenous hydration prescribed, dysentery, or ad-
mission to hospital. For every enrolled case, one to three
matched control children was enrolled. Controls were
matched to every case by age (±2 months for patients aged
0–23 months and ±4 months for patients aged 24–59
months), sex and residence (same or nearby village as the
patient with diarrhea) (Table 3). Controls were enrolled
within 14 days of the index case and were excluded if they
had diarrhea in the prior 7 days. All stools were previously
screened for an array of bacterial, parasitic, and viral path-
ogens [44].
In total, 362 stools from Kenya (181 cases, 181 con-
trols) and 587 stools from The Gambia (266 cases, 321
controls) were available for analysis. A Welch two sam-
ple t-test was used to examine for differences in age be-
tween cases and controls. To assess for differences in
gender between cases and controls a chi square test was
performed. To determine if presence of specific astro-
viruses was associated with diarrhea a conditional logis-
tic regression was performed. To analyze if there were
significant co-infections with astroviruses and other
known pathogens Fisher exact test was used. P values
<0.05 were determined to be significant. All statistical
analyses were done in SAS 9.3 (Carey, NC).
Screening
RT-PCR screening of nucleic acid extracted from stool
filtrates was performed using a one-step kit (Qiagen)
with pan-astrovirus primers SF0073 (5′-GATTGGACTC
GATTTGATGG-3′) and SF0076 (5′-CTGGCTTAACC
CACATTCC-3′) that target the RNA-dependent RNA
Table 3 Patient Demographics
Kenya The Gambia All samples
Cases Controls p Cases Controls p Cases Controls p Total
n = 181 n = 181 n = 266 n = 321 n = 447 n = 502 n = 949
Age (mos) 17.4 17.5 0.985 16.4 18.0 0.0626 16.8 17.8 0.212 17.1
Gender (M) 55.8 % 55.8 % 1.000 56.4 % 55.5 % 0.820 56.2 % 55.6 % 0.859 55.8 %
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polymerase as previously described [11]. Positive samples
were then screened using primers designed to target the
capsid region of classic human astroviruses [Mon269
(5′-CAACTCAGGAAACAGGGTGT-3′) and Mon270
(5′-TCAGATGCATTGTCATTGGT-3′)] and MLB1
[SF0053 (5′-CTGTAGCTCGTGTTAGTCTTAACA-3′)
and SF0061(5′-GTTCATTGGCACCATCAGAAC-3′)]
[11]. Pan-astrovirus derived amplicons from samples ne-
gative in both secondary screens were cloned into
pCR4-TOPO vector (Invitrogen) and Sanger sequenced.
Sequences were compared to the GenBank nr/nt database
on May 7, 2014 and deposited [Genbank: KJ807476 to
KJ807529, KJ777800 to KJ777802].
Full genome sequencing
Deep-sequencing was performed on the stool sample con-
taining the newly described virus VA5 using the Roche Ti-
tanium FLX platform [14]. 1004 viral reads were identified
using Virushunter [45] and assembled using Newbler
generating a contig of 6519 nucleotides. The contig was
confirmed by RT-PCR and 3′ rapid amplification of
cDNA ends. The complete 5′ UTR was not successfully
sequenced after multiple attempts. This 6519 base pair se-
quence was deposited in Genbank [Genbank: KJ656124].
Phylogenetic analysis
MLB3 nucleic acid amplicon sequences were aligned and
maximum-likelihood trees were created by CLUSTALX
version 2.1 with 1000 bootstrap replicates. Phylogenetic
analysis of the recently described VA5 was performed by
aligning amino acid sequences from the complete ORF2
with MUSCLE. Best-fit model was determined using Prot-
test (version 2.4) [46], and maximum-likelihood trees were
generated using Phyml (version 3.0) [47].
Accession numbers for astrovirus sequences used in
Fig. 2 are as follows: Turkey Astrovirus 1: CAB95007;
Turkey Astrovirus 2: NP987088; Turkey Astrovirus 3:
AAV37187; Duck Astrovirus: ACN82429; Guinea Fowl
Astrovirus: JN985815; Chicken Astrovirus 1: NP620618;
Chicken Astrovirus 2: BAB21617; Avian Nephritis Virus 1:
HM029238; Avian Nephritis Virus 2: AEB15604; Pigeon
Astrovirus: CBY02488; Rabbit Astrovirus: AEV92822;
Astrovirus MLB1: YP002290968; Astrovirus MLB2:
YP004934010; Astrovirus MLB3: JX857870; Canine
Astrovirus: AEX00102; Dog Astrovirus: ADL27736;
DogBari Astrovirus: HM045005; Sealion Astrovirus 1:
ACR54272; Sealion Astrovirus 2: ACR54274; Sealion
Astrovirus 4: JN420351; Sealion Astrovirus 5: JN420352;
Sealion Astrovirus 6: JN420353; Sealion Astrovirus 9:
JN420356; Porcine Astrovirus: BAA90309; Porcine Astro-
virus 2: AER30006; Porcine Astrovirus 3: NC019494;
Porcine Astrovirus 4: JF713713; Porcine Astrovirus 5:
JF713711; Swine Astrovirus: ADV16836; Feline Astrovirus
1: AAC13556; Feline Astrovirus 2: NC022249; Human
Astrovirus 1: NP059444; Human Astrovirus 2: L13745;
Human Astrovirus 3: AAD17224; Human Astrovirus 4:
AAY84779; Human Astrovirus 5: AAY46274; Human
Astrovirus 6: CAA86616; Human Astrovirus 7: AAK31913;
Human Astrovirus 8: AAF85964; Dolphin Astrovirus 1:
ACR54280; Dolphin Astrovirus 3: HQ668129; Whale
Astrovirus 2: HQ668143; Bat Astrovirus AFCD337:
ACF75865; Bat Astrovirus LC03: ACN88720; Bat Astro-
virus LD38: ACN88708; Bat Astrovirus LD71: ACN88712;
Ovine Astrovirus: CAB95004; Astrovirus VA1: NC013060;
Astrovirus VA2: GQ502193; Astrovirus VA3: JX857868;
Astrovirus VA4: JX857869; Astrovirus VA5: KJ656124; Fox
Astrovirus: KC692365; Mink Astrovirus: NP795336;
Bovine Astrovirus B76: AED89609; Deer Astrovirus 1:
HM447045; Deer Astrovirus 2: HM447046; Wild boar
Astrovirus: AEZ67026; Murine Astrovirus: NC018702;
Rat Astrovirus: HM450382.
Abbreviation
HAstV: Human Astrovirus.
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